Next-day and 48-hour discharge following alternative access for transcatheter aortic valve implantation
Find out more about this article on Next-day and 48-hour discharge following alternative access for transcatheter aortic valve implantation
Related Articles
Letter: Completeness or complexity? A nuanced reflection on multivessel revascularisation
The study examines the impact of diverse trial designs and patient populations on the assessment of complete revascularization strategies in acute myocardial infarction with multivessel…
Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis
Find out more about this article on Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A…
Can a CT scan characterise and predict HALT evolution?
Study on hypoattenuated leaflet thickening (HALT) observed in TAVI patients and its association with clinical outcomes.
‘A very simple idea’ might make a big difference for stroke patients
Dr. Luciano Sposato admits that a simple change in procedure may have a significant impact on stroke patients.
Prasugrel monotherapy versus standard DAPT in STEMI patients with OCT-guided or angio-guided complete revascularisation: design and rationale of the randomised, multifactorial COMPARE STEMI ONE trial
The COMPARE STEMI ONE trial evaluates an abbreviated DAPT regimen and OCT-guided revascularization in STEMI patients undergoing PCI.
Design and rationale of PRAGUE-26: a multicentre, randomised trial of catheter-directed thrombolysis for intermediate-high risk acute pulmonary embolism
The PRAGUE-26 trial evaluates the clinical outcomes of catheter-directed thrombolysis versus standard anticoagulation in patients with intermediate-high risk acute pulmonary embolism.
Three-year outcomes of EuroCTO (A Randomized Multicentre Trial Comparing Revascularization and Optimal Medical Therapy for Chronic Total Coronary Occlusions)
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
A new implanter classification system for left atrial appendage closure from the European Left Atrial Appendage Closure Club (ELAACC)
A novel implanter classification system for left atrial appendage closure to predict procedural risks and improve safety.
Using pericoronary fat attenuation to guide management after coronary interventions
This study explores the limitations of contemporary coronary intervention strategies and the role of coronary inflammation in the natural history of atherosclerosis.
Using pericoronary fat attenuation to guide management after coronary interventions
This study explores the limitations of contemporary coronary intervention strategies and the role of coronary inflammation in the natural history of atherosclerosis.